“Cell Expansion Global Market – Forecast To 2022”

IQ4I Research & Consultancy Pvt. Ltd.

Cell Expansion Global Market

–Forecast to 2022

Cell Expansion Global Market estimated to be worth $23.9 billion by 2022 IQ4I Research & Consultancy published a new report on “Cell Expansion Global

Market – Forecast To 2022” This report analyzes and studies the overall market, major

drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and

Rest of the World

IQ4I’s Report Contains 128 market data tables and 42 figures spread through 368

pages and an exhaustive TOC on “Cell Expansion Global Market [Products

(Instruments and Consumables), Cell Type (Animal Cell, Human Cell, Bacterial Cell,

Others) Applications (Regenerative Medicine and Stem Cell Research, Cancer Studies

and Others), End-Users (Academics and Research Institutes, Biotech and

Biopharmaceutical Company, Hospitals and Bio banks and Others), Region (North

America, Europe, APAC and RoW)] This report analyzes the cell expansion global market in terms of market revenue ($ million)

for all segments and it enables cell expansion stakeholders such as cell expansion

instrument manufacturers, distributors and wholesalers, OEM/contract manufacturers,

clinics, hospitals, academics & various research institutes to identify and analyze market

expansion opportunities, upcoming technologies and competition in cell expansion global

market.

Cell expansion is defined as the production of daughter cells which basically arise from the

single cell. Cell expansion process plays a key role in therapeutic development, drug

screening and core research. At present, cell expansion is highly used for the expansion of

stem cells in improving outcomes in transplantation and in various diseases such as

rheumatoid arthritis and diabetes. Cell Expansion market is rapidly advancing at a strong

growth rate, as estimated by IQ4I Research, the cell expansion global market is expected to

grow at a double digit CAGR to reach $23,997 million by 2022.

Rising prevalence of chronic diseases, increasing government funding for research,

increased investments in cell based products, growing number of GMP-certified production

are some of the factors aiding in the growth of the market. 3D cell expansion technology and

high-growth in the countries of APAC region are some of the opportunities that are propelling

the growth of the market. However, high cost of cell-based products, use of unregulated

products, quality issues for end users, ethical concerns regarding research on cell biology

and stringent regulations are the factors that are hampering the market.

The cell expansion global market by product is segmented based on products, cell types,

applications and end-users. The market by product is segmented into instruments and



–Forecast to 2022

consumables, based on cell types the market is segmented into animal cell, human cell,

bacterial cell and others, based on applications it is segmented into regenerative medicines

and stem cell research, cancer studies and others. The instruments are segmented into cell

expansion supporting instruments, bioreactors and automatic cell expansion systems. Cell

expansion supporting equipments include flow cytometer, centrifuge, cell counters and

others. Bioreactors are segmented into stirred type bioreactors, microcarrier-based

anchorage-dependent stirred type bioreactors, suspension-based anchorage independent

stirred type bioreactors, hollow fibre/perfusion bioreactors, bubble column and airlift

bioreactor, single/disposable use bioreactor and others. Consumables are segmented into

reagents, media, sera and disposables. Disposables are further sub-segmented into culture

vessels, bioreactor accessories and others. Among bioreactors, single use bioreactors are

expected to drive the market high with a high double digit CAGR during 2015-2022. For

instance, ABEC, a U.S. based bioprocess solution company, launched a ‘Custom Single

Run’ (CSR) system in November 2015, with a total volume of 4,300L and a working volume

of 3,500L, making it the largest single use bioreactor available in the market.

By cell types, the cell expansion markets are divided into animal cells, human cells, bacterial

cells and others. The human cell includes adult stem cells, induced pluripotent stem cells

and embryonic stem cells. Adult stem cells are segmented into mesenchymal stem cells,

hematopoietic stem cells and neural stem cells. Mesenchymal stem cells are expected to

grow a high double digit CAGR due to increasing acceptance of stem cell therapies.

By application, the cell expansion markets are divided into regenerative medicine and stem

cell research, cancer studies and others. Regenerative medicine is expected to grow at a

high double digit CAGR from 2015-2022 by addressing many addressing many unmet

therapeutic needs. The end users of the cell expansion market are segmented into

academics and research institutes, biotechnology and biopharmaceutical companies,

hospital and bio-banks and others. Hospitals and biobanks are expected to grow at a high

double digit CAGR from 2015-2022.

The cell expansion global market by geography is divided into North America, Europe, Asia-

Pacific and Rest of the World (RoW). North America commanded the largest market share in

2015 due to increase in governmental funding and investments and better accessibility to

healthcare facilities has led the market growth in this region. However, Asia- Pacific region is

expected to have highest growth rate from 2015-2022 due to rising prevalence of lifestyle

diseases and government initiatives in establishing innovative technologies.



–Forecast to 2022

The major players in the cell expansion global market are Becton Dickenson and Company

(U.S.), Corning Inc (U.S.), Danaher Corporation (U.S.), Eppendorf AG (Germany), GE

Healthcare (U.K.), Lonza Group (Switzerland), Merck KGaA (Germany), Miltenyi Biotec

(Germany), Stemcell Technologies (Canada), Terumo Corporation (Japan) and

ThermoFisher Scientific Inc. (U.S.).

Reasons for buying this report:

Analysis of the cell expansion global market by identifying various segments by

products, type, application, end-users and geography.

Revenue forecast of the cell expansion global market and strategic analysis of each

submarket with respect to segmental growth trends.

Analysis of the major market trends and factors driving or inhibiting the growth of the

cell expansion global market.

Revenue forecast of the cell expansion global market with respect to North America,

Europe, Asia-Pacific and the Rest of the World (RoW) regions.

Analysis of the opportunities for stakeholders by identifying the high-growth

segments of the market.

Market share analysis of key players in cell expansion global market, details of their

product offerings, revenues, business strategies and SWOTs

Patent trends, supply chain analysis of the cell expansion global market

Single-use bioreactors market share analysis by major players 2015 (%)

Established and Emerging players (66 companies) and their product offerings.



–Forecast to 2022

FIGURE 1

CELL EXPANSION GLOBAL MARKET SEGMENTATION


Instruments

Centrifuge

ByProducts

Animal Cell

By Cell Types

Consumables Regenerative

Medicine

Human Cell

By Applications

Adult Stem Cell

Mesenchymal

Disposables

Reagents,

Media & Sera

Flow Cytometer

Supporting

Equipment

Others

Culture vessels

Embryonic

stem cell

Induced

Pluripotent

Cancer Studies

Hollow Fiber

Bubble column/

Airlift

Bioreactor

Accessories

Suspension

Based

Microcarrier-

Based

Single use

Others

Stirred Type

Bioreactor

Cell Counter

Others

Hematopoietic

Neural

By End Users

Others

Research

Institutes

Biopharma,

Biotech

Hospitals and

Bio Banks

Others

Bacterial Cell

“Cell Expansion Global Market – Forecast To 2022”

Healthcare

Transcript of “Cell Expansion Global Market – Forecast To 2022”